Vigil Neuroscience Inc (VIGL) concluded trading on Thursday at a closing price of $4.48, with 16.82 million shares of worth about $75.37 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 22.74% during that period and on June 27, 2024 the price saw a gain of about 18.52%. Currently the company’s common shares owned by public are about 35.88M shares, out of which, 15.54M shares are available for trading.
Stock saw a price change of 6.92% in past 5 days and over the past one month there was a price change of 35.35%. Year-to-date (YTD), VIGL shares are showing a performance of 32.54% which decreased to -51.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.47 but also hit the highest price of $10.22 during that period. The average intraday trading volume for Vigil Neuroscience Inc shares is 164.15K. The stock is currently trading 16.45% above its 20-day simple moving average (SMA20), while that difference is up 30.98% for SMA50 and it goes to 10.47% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Vigil Neuroscience Inc (NASDAQ: VIGL) currently have 35.88M outstanding shares and institutions hold larger chunk of about 39.09% of that.
The stock has a current market capitalization of $168.36M and its 3Y-monthly beta is at 1.99. It has posted earnings per share of -$2.12 in the same period. It has Quick Ratio of 12.38 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VIGL, volatility over the week remained 13.87% while standing at 17.20% over the month.
Stock’s fiscal year EPS is expected to rise by 9.21% while it is estimated to increase by 1.75% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Morgan Stanley on December 19, 2023 offering an Underweight rating for the stock and assigned a target price range of between $13 and $4 to it. Coverage by JMP Securities stated Vigil Neuroscience Inc (VIGL) stock as a Mkt outperform in their note to investors on October 18, 2023, suggesting a price target of $23 for the stock. On March 31, 2023, Mizuho Initiated their recommendations, while on September 16, 2022, Wedbush Initiated their ratings for the stock with a price target of $19. Stock get a Buy rating from H.C. Wainwright on August 29, 2022.
